Literature DB >> 29600913

Natural history of cavernous sinus meningiomas.

Aymeric Amelot1,2, Remy van Effenterre1,2, Michel Kalamarides1,2, Philippe Cornu1,2, Anne-Laure Boch1,2.   

Abstract

OBJECTIVEMeningiomas confined to the cavernous sinus (MCSs) are benign tumors. Due to the high risk of severe complications, the intracavernous surgical procedure was abandoned in favor of radiotherapy. However, the choice of treatment remains complicated due to the fact that the natural history of this lesion has not yet been described.METHODSThe authors studied the natural history of this lesion using a prospective series of 53 consecutive patients suffering from MCSs. The median follow-up duration was 10.2 years (range 2-25 years), from 1990 to 2016.RESULTSPatients ranged in age from 30 to 72 years (mean 53 years). The meningiomas were diagnosed by major symptoms (mainly oculomotor palsy and neuralgia experienced in 28 patients), minor symptoms (headache, intermittent diplopia in 15 patients), or incidental findings (10 patients). Simple symptomatic treatment (short courses of corticosteroids and carbamazepine) allowed patients to become asymptomatic in 19 (67.9%) of 28 cases experiencing major symptoms, and for 12 (80%) of 15 patients with initial minor symptoms (p < 0.0001). All patients with incidental findings remained asymptomatic. Forty four (83%) of 53 MCSs did not show any significant growth and 42 (80%) of 53 patients were not symptomatic at the end of follow-up (p < 0.001). The radiographic progression-free survival rates (± SD) at 5, 10, and 20 years were 90% ± 4.2%, 82% ± 5.7%, and 70% ± 10.2%, respectively. Five patients (9.4%) with no evidence of any effect of the initial medical treatment desired additional conventional radiation therapy.CONCLUSIONSBecause of the capricious, unpredictable, and slow growth of MCSs, together with high growth variability from one patient to the next, the symptomatic medical treatment of these tumors is a highly effective method. This series shows that these lesions are naturally, clinically, and radiologically indolent.

Entities:  

Keywords:  CN = cranial nerve; CS = cavernous sinus; MCS = meningioma of the CS; PFS = progression-free survival; cavernous sinus meningioma; corticosteroids; natural history; oncology; treatment

Year:  2018        PMID: 29600913     DOI: 10.3171/2017.7.JNS17662

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  7 in total

1.  Evidence-based treatment of cavernous sinus meningioma.

Authors:  Javad Hekmatpanah
Journal:  Surg Neurol Int       Date:  2019-11-22

2.  Blood Supply of Cranial Nerves Passing Through the Cavernous Sinus: An Anatomical Study and Its Implications for Microsurgical and Endoscopic Cavernous Sinus Surgery.

Authors:  Edinson Najera; Bilal Ibrahim; Baha'eddin A Muhsen; Assad Ali; Clariza Sanchez; Michal Obrzut; Hamid Borghei-Razavi; Badih Adada
Journal:  Front Oncol       Date:  2021-10-08       Impact factor: 6.244

Review 3.  Midline Skull Base Meningiomas: Transcranial and Endonasal Perspectives.

Authors:  Ciro Mastantuoni; Luigi Maria Cavallo; Felice Esposito; Elena d'Avella; Oreste de Divitiis; Teresa Somma; Andrea Bocchino; Gianluca Lorenzo Fabozzi; Paolo Cappabianca; Domenico Solari
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

4.  Predictors of improvement in quality of life at 12-month follow-up in patients undergoing anterior endoscopic skull base surgery.

Authors:  Quinlan D Buchlak; Nazanin Esmaili; Christine Bennett; Yi Yuen Wang; James King; Tony Goldschlager
Journal:  PLoS One       Date:  2022-07-27       Impact factor: 3.752

5.  Management of cavernous sinus meningiomas: Consensus statement on behalf of the EANS skull base section.

Authors:  Marco V Corniola; Pierre-Hugues Roche; Michaël Bruneau; Luigi M Cavallo; Roy T Daniel; Mahmoud Messerer; Sebastien Froelich; Paul A Gardner; Fred Gentili; Takeshi Kawase; Dimitrios Paraskevopoulos; Jean Régis; Henry W S Schroeder; Theodore H Schwartz; Marc Sindou; Jan F Cornelius; Marcos Tatagiba; Torstein R Meling
Journal:  Brain Spine       Date:  2022-01-21

Review 6.  STA-MCA Bypass in Carotid Stenosis after Radiosurgery for Cavernous Sinus Meningioma.

Authors:  Marco Vincenzo Corniola; Marton König; Torstein Ragnar Meling
Journal:  Cancers (Basel)       Date:  2021-05-17       Impact factor: 6.639

7.  An international multicenter matched cohort analysis of incidental meningioma progression during active surveillance or after stereotactic radiosurgery: the IMPASSE study.

Authors:  Jason Sheehan; Stylianos Pikis; Abdurrahman I Islim; Ching-Jen Chen; Adomas Bunevicius; Selcuk Peker; Yavuz Samanci; Ahmed M Nabeel; Wael A Reda; Sameh R Tawadros; Amr M N El-Shehaby; Khaled Abdelkarim; Reem M Emad; Violaine Delabar; David Mathieu; Cheng-Chia Lee; Huai-Che Yang; Roman Liscak; Jaromir Hanuska; Roberto Martinez Alvarez; Dev Patel; Douglas Kondziolka; Nuria Martinez Moreno; Manjul Tripathi; Herwin Speckter; Camilo Albert; Greg N Bowden; Ronald J Benveniste; Lawrence Dade Lunsford; Michael D Jenkinson
Journal:  Neuro Oncol       Date:  2022-01-05       Impact factor: 13.029

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.